Early Remission of Type B Insulin Resistance Syndrome Achieved by Glucocorticoid-based Immunosuppressive Therapy and Visualized by Intermittently Scanned Continuous Glucose Monitoring
Internal Medicine · 2026
DOI: 10.2169/internalmedicine.7357-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine, 2026. Verfasst von Yuki Matsumura-Tojima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Tokushima Red Cross Hospital, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, Tokushima Red Cross Hospital, Japan.
Zitieren
APA
Matsumura-Tojima, Y., Sugita, T., Tanizaki, Y., Tani, M., Wada, A., & Kondo, T. (2026). Early Remission of Type B Insulin Resistance Syndrome Achieved by Glucocorticoid-based Immunosuppressive Therapy and Visualized by Intermittently Scanned Continuous Glucose Monitoring. Internal Medicine. https://doi.org/10.2169/internalmedicine.7357-26
Vancouver
Matsumura-Tojima Y, Sugita T, Tanizaki Y, Tani M, Wada A, Kondo T. Early Remission of Type B Insulin Resistance Syndrome Achieved by Glucocorticoid-based Immunosuppressive Therapy and Visualized by Intermittently Scanned Continuous Glucose Monitoring. Internal Medicine. 2026. doi:10.2169/internalmedicine.7357-26
BibTeX
@article{MatsumuraTojima2026,
author = {Matsumura-Tojima, Yuki and Sugita, Tomoya and Tanizaki, Yusuke and Tani, Makiko and Wada, Ayumi and Kondo, Takeshi},
title = {Early Remission of Type B Insulin Resistance Syndrome Achieved by Glucocorticoid-based Immunosuppressive Therapy and Visualized by Intermittently Scanned Continuous Glucose Monitoring},
journal = {Internal Medicine},
year = {2026},
doi = {10.2169/internalmedicine.7357-26}
}
EUVIMED